About
Genome Editing Technologies
Areas of Focus
Categories
Biologics & BiopharmaceuticalVirus TechnologyGene Therapy, RNA & Peptide TherapyDrug Delivery & FormulationSan Diego & Southern California
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
776
By Phase
PHASE1: 5PHASE1/PHASE2: 1
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 2TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
Today
Hover over trial bars to see details
Recent Trials
NCT06014762Lead Sponsor
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
PHASE1Recruiting
120 participants
Started: Apr 16, 2024 · Completed: Mar 31, 2041
NCT04960579Lead Sponsor
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
PHASE1Recruiting
231 participants
Started: May 5, 2022 · Completed: Dec 31, 2039
NCT05239143Lead Sponsor
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
180 participants
Started: Feb 15, 2022 · Completed: Apr 30, 2039
NCT04249947Lead Sponsor
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)
PHASE1Terminated
40 participants
Started: Feb 28, 2020 · Completed: Sep 30, 2024
NCT03741127Lead Sponsor
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
PHASE1Active, not recruiting
100 participants
Started: Oct 29, 2018 · Completed: Nov 30, 2032
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...